These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 3404643

  • 1. [Evaluation on ceftriaxone administered intravenously in neonates].
    Nakazawa S, Satoh H, Narita A, Suzuki H, Nakazawa S, Matsumoto K, Nakanishi Y, Niino K, Chikaoka H, Kamigaki M.
    Jpn J Antibiot; 1988 Mar; 41(3):225-35. PubMed ID: 3404643
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacokinetic and clinical evaluation of ceftriaxone in neonates and premature infants].
    Toyonaga Y, Sugita M, Hori M.
    Jpn J Antibiot; 1988 Mar; 41(3):244-61. PubMed ID: 3404645
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacokinetic and clinical evaluations on ceftriaxone in neonates and premature infants].
    Shiro H, Kusumoto Y, Satoh Y, Oikawa T, Osano M.
    Jpn J Antibiot; 1988 Mar; 41(3):236-43. PubMed ID: 3404644
    [Abstract] [Full Text] [Related]

  • 4. [Clinical evaluation of ceftriaxone in the treatment of neonatal infections].
    Okura K, Yamamoto H, Yamaoka K, Kubo K, Mitsuyoshi I, Haruta T, Kobayashi Y.
    Jpn J Antibiot; 1988 Feb; 41(2):152-64. PubMed ID: 3286924
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacokinetic and clinical evaluations of ceftriaxone in neonates and premature infants].
    Motohiro T, Oda K, Aramaki M, Tanaka K, Kawakami A, Shimada Y, Koga T, Tomita S, Sakata Y, Fujimoto T.
    Jpn J Antibiot; 1988 Mar; 41(3):276-305. PubMed ID: 3404647
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Pharmacokinetic and clinical evaluations on ceftriaxone in neonates].
    Iwai N, Nakamura H, Miyazu M, Katayama M, Taneda Y.
    Jpn J Antibiot; 1988 Mar; 41(3):262-75. PubMed ID: 3404646
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of the pharmacokinetics of ceftriaxone in neonates].
    Sunakawa K, Sato Y.
    Jpn J Antibiot; 1988 Feb; 41(2):128-32. PubMed ID: 3373735
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Fundamental and clinical evaluation of ceftriaxone in the field of pediatrics].
    Satoh Y, Iwata S, Akita H, Murai T, Hayano S, Oikawa T, Osano M.
    Jpn J Antibiot; 1984 Nov; 37(11):2034-48. PubMed ID: 6098700
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of ceftriaxone in the pediatric field].
    Minamitani M, Hachimori K, Kaneda K.
    Jpn J Antibiot; 1984 Dec; 37(12):2283-97. PubMed ID: 6098721
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacokinetic and clinical studies on ceftriaxone in the perinatal period].
    Yamamoto T, Yasuda J, Kanao M, Okada H.
    Jpn J Antibiot; 1988 Feb; 41(2):201-9. PubMed ID: 3373740
    [Abstract] [Full Text] [Related]

  • 15. [Pharmacokinetic and clinical studies of ceftizoxime in newborn infants].
    Sato H, Nakazawa S, Narita A, Nakazawa S, Matsumoto K, Suzuki H, Nakanishi Y, Chikaoka H, Kamigaki M, Niino K.
    Jpn J Antibiot; 1988 Aug; 41(8):1053-64. PubMed ID: 3172466
    [Abstract] [Full Text] [Related]

  • 16. [Fundamental and clinical evaluation on ceftriaxone in the pediatric field].
    Toyonaga Y, Kurosu Y, Uekusa T, Nakamura H, Sugita M, Okabe T, Kawamura K, Seo K, Takahashi T, Hori M.
    Jpn J Antibiot; 1984 Nov; 37(11):2060-82. PubMed ID: 6098702
    [Abstract] [Full Text] [Related]

  • 17. [Bacteriological, pharmacokinetic and clinical evaluations of ceftriaxone in the pediatric field. Pediatric study group of ceftriaxone].
    Fujii R, Meguro H, Arimasu O, Tagaya M, Fujita K, Sakata H, Yoshioka H, Maruyama S, Sanae N, Nagamatsu I.
    Jpn J Antibiot; 1986 Aug; 39(8):1988-2008. PubMed ID: 3540338
    [Abstract] [Full Text] [Related]

  • 18. [Clinical and pharmacokinetics studies of ceftriaxone upon 2g once daily administration in respiratory tract infections].
    Ishioka S, Yamakido H, Inyaku K, Hasegawa K, Yamakido M, Akagawa T, Kuwabara M, Kodomari Y, Kawamoto M, Arita H.
    Jpn J Antibiot; 1991 Jun; 44(6):605-13. PubMed ID: 1890721
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the first report). Study on effectiveness and safety in mono-therapy with aztreonam. A study of aztreonam in the Perinatal Co-research Group].
    Fuji R, Hashira S, Tajima T, Meguro H, Abe T, Sakata H, Kakehashi H, Fujita K, Murono K, Kaeriyama M.
    Jpn J Antibiot; 1990 Mar; 43(3):543-62. PubMed ID: 2197468
    [Abstract] [Full Text] [Related]

  • 20. [Clinical studies and sputum levels of ceftriaxone once daily administration in respiratory tract infection].
    Kuwabara M, Sasaki H, Fukuhara H, Arita H, Inamizu T, Sadamoto K, Kimura T, Yamane K, Shigemoto M, Kawamoto M.
    Jpn J Antibiot; 1989 Apr; 42(4):921-9. PubMed ID: 2671426
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.